NO970477D0 - Inhibisjon av leukotrien biosyntese med ureaderivater - Google Patents

Inhibisjon av leukotrien biosyntese med ureaderivater

Info

Publication number: NO970477D0
Authority: NO; Norway
Prior art keywords: leukotriene biosynthesis; inhibition; urea derivatives; compound; pharmaceutical composition
Prior art date: 1994-08-04

Application number

NO970477A

Other languages

English (en)

Other versions

NO970477L (no

NO315786B1 (no

Inventor

Stephen L Crooks

Bryon A Merrill

Paul D Wightman

Original Assignee

Minnesota Mining & Mfg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-04

Filing date

1997-02-03

Publication date

1997-02-03

1995-05-31 Priority claimed from US08/455,643 external-priority patent/US5612377A/en

1997-02-03 Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg

1997-02-03 Publication of NO970477D0 publication Critical patent/NO970477D0/no

1997-03-14 Publication of NO970477L publication Critical patent/NO970477L/no

2003-10-27 Publication of NO315786B1 publication Critical patent/NO315786B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO19970477A 1994-08-04 1997-02-03 Inhibisjon av leukotrienbiosyntese med ureaderivater NO315786B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28601794A	1994-08-04	1994-08-04
US08/455,643 US5612377A (en)	1994-08-04	1995-05-31	Method of inhibiting leukotriene biosynthesis
PCT/US1995/007667 WO1996003983A1 (en)	1994-08-04	1995-07-14	Inhibition of leukotriene biosynthesis with urea derivatives

Publications (3)

Publication Number	Publication Date
NO970477D0 true NO970477D0 (no)	1997-02-03
NO970477L NO970477L (no)	1997-03-14
NO315786B1 NO315786B1 (no)	2003-10-27

Family

ID=26963530

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19970477A NO315786B1 (no)	1994-08-04	1997-02-03	Inhibisjon av leukotrienbiosyntese med ureaderivater

Country Status (19)

Country	Link
EP (1)	EP0777471B1 (no)
JP (1)	JPH10503771A (no)
AT (1)	ATE228359T1 (no)
AU (1)	AU685980B2 (no)
BR (1)	BR9508521A (no)
CA (1)	CA2196701A1 (no)
CZ (1)	CZ287034B6 (no)
DE (1)	DE69528984T2 (no)
DK (1)	DK0777471T3 (no)
ES (1)	ES2185708T3 (no)
FI (1)	FI970452L (no)
HU (1)	HUT76830A (no)
IL (1)	IL114646A (no)
NO (1)	NO315786B1 (no)
NZ (1)	NZ290236A (no)
PL (1)	PL180668B1 (no)
PT (1)	PT777471E (no)
SK (1)	SK282777B6 (no)
WO (1)	WO1996003983A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
FR2880022B1 (fr) *	2004-12-24	2007-08-24	Mayoly Spindler Soc Par Action	Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5066658A (en) *	1988-11-10	1991-11-19	Ortho Pharmaceutical Corporation	Substituted hydroxyureas
EP0456760A4 (en) *	1989-02-01	1992-01-08	Abbott Laboratories	Lipoxygenase inhibiting compounds
JP2528741B2 (ja) *	1991-01-09	1996-08-28	ファイザー製薬株式会社	オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物

1995
- 1995-07-14 AU AU30917/95A patent/AU685980B2/en not_active Ceased
- 1995-07-14 NZ NZ290236A patent/NZ290236A/xx unknown
- 1995-07-14 AT AT95926593T patent/ATE228359T1/de not_active IP Right Cessation
- 1995-07-14 BR BR9508521A patent/BR9508521A/pt not_active Application Discontinuation
- 1995-07-14 ES ES95926593T patent/ES2185708T3/es not_active Expired - Lifetime
- 1995-07-14 HU HU9700338A patent/HUT76830A/hu unknown
- 1995-07-14 SK SK110-97A patent/SK282777B6/sk unknown
- 1995-07-14 CA CA002196701A patent/CA2196701A1/en not_active Abandoned
- 1995-07-14 DE DE69528984T patent/DE69528984T2/de not_active Expired - Fee Related
- 1995-07-14 PL PL95318539A patent/PL180668B1/pl not_active IP Right Cessation
- 1995-07-14 WO PCT/US1995/007667 patent/WO1996003983A1/en not_active Ceased
- 1995-07-14 CZ CZ1997312A patent/CZ287034B6/cs not_active IP Right Cessation
- 1995-07-14 JP JP8506485A patent/JPH10503771A/ja not_active Withdrawn
- 1995-07-14 DK DK95926593T patent/DK0777471T3/da active
- 1995-07-14 PT PT95926593T patent/PT777471E/pt unknown
- 1995-07-14 EP EP95926593A patent/EP0777471B1/en not_active Expired - Lifetime
- 1995-07-14 FI FI970452A patent/FI970452L/fi not_active IP Right Cessation
- 1995-07-18 IL IL11464695A patent/IL114646A/xx not_active IP Right Cessation
1997
- 1997-02-03 NO NO19970477A patent/NO315786B1/no unknown

Also Published As

Publication number	Publication date
FI970452A7 (fi)	1997-02-03
DE69528984D1 (de)	2003-01-09
DK0777471T3 (da)	2003-03-17
CA2196701A1 (en)	1996-02-15
EP0777471A1 (en)	1997-06-11
PL318539A1 (en)	1997-06-23
ES2185708T3 (es)	2003-05-01
NO970477L (no)	1997-03-14
SK11097A3 (en)	1997-09-10
AU3091795A (en)	1996-03-04
WO1996003983A1 (en)	1996-02-15
HUT76830A (en)	1997-11-28
JPH10503771A (ja)	1998-04-07
NO315786B1 (no)	2003-10-27
AU685980B2 (en)	1998-01-29
PL180668B1 (pl)	2001-03-30
NZ290236A (en)	1998-12-23
IL114646A (en)	2000-02-29
FI970452A0 (fi)	1997-02-03
ATE228359T1 (de)	2002-12-15
DE69528984T2 (de)	2003-09-04
MX9700860A (es)	1997-10-31
EP0777471B1 (en)	2002-11-27
CZ31297A3 (en)	1997-09-17
SK282777B6 (sk)	2002-12-03
PT777471E (pt)	2003-04-30
CZ287034B6 (en)	2000-08-16
IL114646A0 (en)	1995-11-27
BR9508521A (pt)	1997-10-28
FI970452L (fi)	1997-02-03

Publication	Publication Date	Title
ATE203515T1 (de)	2001-08-15	Meta-substituierte phenylsulphonamidderivate
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
CA2216796A1 (en)	1996-10-03	Quinazoline derivatives
YU69902A (sh)	2005-07-19	Novi derivati piperazina
ATE202337T1 (de)	2001-07-15	Cyclopropylalkansäurederivate
BG103947A (en)	2000-07-31	Derivatives of 9-oxymerythromycin
YU11997A (sh)	1999-09-27	Laktamski derivati i njihove farmaceutske kompozicije
NZ233735A (en)	1992-10-28	Heterocyclic substituted aminophenol derivatives
MX9708452A (es)	1998-06-30	Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
NO960632D0 (no)	1996-02-16	Nye bis-naftalimider for behandling av kreft
DE69330601D1 (de)	2001-09-20	Serotoninergische ergolin derivate
DE60005517D1 (de)	2003-10-30	Kaliumkanal-blockierende mittel
NO970477D0 (no)	1997-02-03	Inhibisjon av leukotrien biosyntese med ureaderivater
AP9801235A0 (en)	1999-11-07	Erythromycin derivatives.
MY115430A (en)	2003-06-30	Glutaramide derivatives.
ATE94050T1 (de)	1993-09-15	Mittel zur verhinderung von zahnbelagbildung.
WO1995022544A3 (de)	1996-09-26	Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
CA2187402A1 (en)	1997-04-11	Quinoxaline Derivatives for Treating Tinnitus
DK1264836T3 (da)	2005-03-07	Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
AR015458A1 (es)	2001-05-02	Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene.
PT971714E (pt)	2002-12-31	Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia